KENNESAW, Ga., Jan. 25, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that they will be attending the American Academy of Orthopaedic Surgeons (AAOS) annual meeting, February 8 through February 10, 2012. The AAOS 2012 annual meeting will be held at the Moscone Center in San Francisco, California.
MiMedx will be presenting the Company's biomaterial platform technologies developed for use in soft tissue trauma, nerve repair, spinal applications and sports medicine. During the conference, MiMedx will be presenting HydroFix®, one its device technologies, and AmnioFix®, one of is tissue technologies, and highlighting the Company's offerings, AmnioFix® Injectable and AmnioFix® Wrap.
Throughout the conference, MiMedx plans to sponsor various meetings with physicians and scientists to discuss and demonstrate the benefits and potential of these offerings. MiMedx Group will be located in Booth 2309 at the Moscone Center.About the Company MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. " Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies, processed from the human amniotic membrane, utilize our proprietary Purion™ process that was developed by our wholly-owned subsidiary, Surgical Biologics, to produce a safe, effective and minimally manipulated implant. Surgical Biologics is the leading supplier of amniotic tissue, having supplied over 60,000 implants to date to distributors and OEMs for application in the Ophthalmic, Orthopedics, Spine, Wound Care and Dental sectors of healthcare. SOURCE MiMedx Group, Inc.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV